National Institute for Research in Tuberculosis, Chennai, India   Report issue

Government Phase 2 Phase 3
Founded: Chennai India (1956)

Organization Overview

First Clinical Trial
2001
NCT00376012
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu | National Institute for Research in Tuberculosis | Scientist 'B', Tuberculosis Research Centre (ICMR), Chennai, India | Scientist 'F', Tuberculosis Research Centre (ICMR), Chennai, India | Tuberculosis Research Centre, Chennai, India | Tuberculosis Research Centre, India

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

Elephantiasis (Phase 2)

Elephantiasis, Filarial (Phase 2)

Filariasis (Phase 2)

HIV Infections (Phase 3)

Tuberculosis (Phase 3)

Tuberculosis, Meningeal (Phase 2)

Tuberculosis, Pulmonary (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 17